uniQure N.V. - Ordinary Shares (NQ:QURE)

uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

May 07, 2024

Pfizer won FDA approval for a new hemophilia B gene therapy, a rival to Hemgenix from CSL and Uniqure.

Pfizer Now Rivals The World's Most Expensive Medicine After FDA Approves Gene Therapy

April 26, 2024

Via Investor's Business Daily

AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday

March 04, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Recap: uniQure Q4 Earnings

February 28, 2024

Via Benzinga

Why Shares of uniQure Are Up Thursday

October 05, 2023

The company announced a reorganization that included layoffs.

Via The Motley Fool

Why Shares of uniQure Are Dropping Tuesday

September 05, 2023

The company is facing being delisted from the S&P 600 Index.

Via The Motley Fool

Topics Stocks

Analyst Expectations for uniQure's Future

August 02, 2023

Via Benzinga

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

February 29, 2024

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.

Via Benzinga

uniQure Announces 2023 Financial Results and Highlights Recent Company Progress

February 28, 2024

Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

December 19, 2023

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy...

Via Benzinga

Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday

December 19, 2023

U.S. stocks traded higher, with the Dow Jones index gaining around 150 points on Tuesday. Shares of bluebird bio, Inc. (NASDAQ: BLUE) shares fell sharply during Tuesday’s session after the company...

Via Benzinga

Topics Stocks

uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease

December 19, 2023

uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 08, 2023

uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease

November 29, 2023

Patient enrollment expected to begin in first half of 2024

If you are hungry for high-risk returns, then these micro-cap stocks to buy could be your winning ticket to future yields.

3 Micro-Cap Stocks That Could Be Moonshots

November 14, 2023

uniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress

November 07, 2023

Pre-market stock movers are a hot topic on Thursday and we're checking out all of the biggest ones worth watching this morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

November 02, 2023

uniQure Announces Major Presence at the European Society of Gene and Cell Therapy (ESGCT) Annual Meeting

October 24, 2023

uniQure N.V. (NASDAQ: QURE) announced to cut about 20% of its total workforce, or about 114 jobs, and end investments in more than half of its research and technology

Gene Therapy Player UniQure To Lay Off 20% Of Workforce, Stop Parkinson's Study

October 05, 2023

Via Benzinga

uniQure Announces Strategic Reorganization to Reduce Operating Expenses and Support Advancement of Multiple Clinical-Stage Programs

October 05, 2023

uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 02, 2023

Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions.

Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?

September 15, 2023

Via Investor's Business Daily

Stocks That Hit 52-Week Lows On Monday

October 02, 2023

On Monday, 369 companies set new 52-week lows.

Via Benzinga

uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-260 Gene Therapy for Refractory Mesial Temporal Lobe Epilepsy

September 05, 2023

Clinical trial initiation expected in the fourth quarter of 2023

During Tuesday's session, 275 companies made new 52-week lows.

Stocks That Hit 52-Week Lows On Tuesday

September 19, 2023

Via Benzinga

Airbnb, Blackstone Rise On News They'll Join S&P 500 Index

September 02, 2023

ABNB and BX will join Sept. 18 as part of a quarterly rebalancing.

Via Investor's Business Daily

Topics Stocks

Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

September 05, 2023

Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform...

Via Benzinga

3 Tantalizing Stocks to Buy for Under $10

August 26, 2023

While investors should stick with the predictable ideas, those that want robust returns should target these stocks under $10 to buy.

uniQure Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress

August 01, 2023